Familial amyloidosis modeled in vitro using iPSC technology

Researchers from Boston University School of Medicine and Boston Medical Center have generated the first known disease-specific induced pluripotent stem cell lines from a patient with familial transthyretin amyloidosis .

http://www.medilexicon.com/medicalnews.php?newsid=268268